The FDA's annual generic drug approvals save billions each year, with savings fluctuating based on which brand drugs lose patent protection. In 2023, generics saved Americans $445 billion.
PAMORAs like methylnaltrexone, naloxegol, and naldemedine treat opioid-induced constipation without reducing pain relief. Learn how they work, who benefits most, and why they’re often more effective than traditional laxatives.
Fulminant hepatic failure from medications kills quickly - but early recognition saves lives. Learn the warning signs, key lab values, and emergency steps to act before it's too late.
Lithium, valproate, and carbamazepine are powerful mood stabilizers with dangerous drug interactions. Learn how NSAIDs, diuretics, and other meds can affect their levels-and what to do to stay safe.
Levothyroxine and proton pump inhibitors can interfere with each other, reducing thyroid hormone absorption. Learn how PPIs affect levothyroxine, what to do if your TSH rises, and safer alternatives to manage both conditions.
Switching to generic medications is safe for most people, but monitoring your health is crucial - especially if you're on drugs with narrow therapeutic indices like thyroid meds, blood thinners, or seizure drugs. Track symptoms, lab results, and NDC numbers after the switch.
Learn how to read OTC drug labels to avoid dangerous overdoses. Understand active ingredients like acetaminophen and ibuprofen, why brand names are misleading, and how to safely combine medications.
Clinical trials show what side effects a drug might cause under ideal conditions. Real-world data shows what actually happens when millions take it. Understanding both is key to knowing your true risk.
The FDA inspects over 13,000 manufacturing sites annually to ensure drugs, devices, and food meet safety standards. Learn how inspections work, what causes failures, and how to prepare for them.
The FDA's 2025 update to biosimilar approval rules removes unnecessary clinical trials, making cheaper biologic alternatives faster and easier to bring to market. Learn how biosimilars are reviewed, why they're different from generics, and what this means for patients.